Oxford Biomedica shares surge after it raises its forecast for COVID-19 vaccine revenues
A look at the major movers on the London market on Tuesday
Oxford Biomedica PLC (LON:OXB) has been boosted by vaccine news.
The company, a key manufacturer of the Oxford/AstraZeneca PLC (LON:AZN) COVID-19 vaccine, has doubled its expectations for revenue from the contract.
The gene and cell therapy group said AstraZeneca had increased the number of batches required for the jab in the second half.
It now estimates its revenues from the vaccine will be £100mln, up from previous forecasts of £50mln.
The company s shares have jumped 128p or 12.77% to 1130p, making it the biggest riser in the FTSE 350.
TAGESVORSCHAU/Mittwoch, 19 Mai (vorläufige Fassung)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DGAP-News: DEFAMA mit FFO-Steigerung von 29% im ersten Quartal
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
PTA-CMS: Edel SE & Co KGaA: Bekanntmachung entsprechend Art 5 Abs 1 lit b) und Abs 3 der Verordnung (EU) Nr 596/2014 (MAR) - i V m Art 2 Abs 2 und Abs 3 der Delegierten Verordnung (EU) Nr 2016/105
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DGAP-News: Heidelberg Pharma AG: Hauptversammlung 2021 der Heidelberg Pharma stimmt allen Beschlussvorschlägen zu (deutsch) ()
aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.